NCT00335478View on ClinicalTrials.gov

Daptomycin in Treating Neutropenia and Fever in Patients With Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
FeverSweatingHot FlashesInfectionNeutropeniaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

Daptomycin

daptomycin 6 mg/kg over 30 minutes every 24 hours until patient is afebrile and ANC is \>500 cells/mm\^3.

Trial Locations (1)

97239

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
lead

OHSU Knight Cancer Institute

OTHER

NCT00335478 - Daptomycin in Treating Neutropenia and Fever in Patients With Cancer | Biotech Hunter | Biotech Hunter